Category Archives: Parkinson’s Treatment

WATCH TIME: 5 minutes "I think one of the biggest things I've learned in this study is that 100% of everyone has the patient's care and the best interest of the patient at heart, and so people are really receptive." A relatively new concept, the Cleveland Clinic (CCF)s Parkinsons Inpatient Program implements system and patient-level interventions to enhance recovery for patients with Parkinson disease (PD). At the enterprise level of the program, modifications were made to electronic health records, including best practice alerts and notifications for PD contraindicated medications. Continue reading →

AskBios investigational gene therapy AB-1005 has been granted fast-track designation for Parkinsons disease by the U.S. Food and Drug Administration (FDA), and innovation passport designation by the regulatory agency in the U.K. These designations are meant to accelerate the development and review process of therapy candidates designed to treat serious conditions and fill unmet clinical needs, which may offer significant benefits over approved treatments Continue reading →

Clumps of RNA-binding proteins have been discovered in the nucleus of nerve cells derived from people with Parkinsons disease, according to a new study. Continue reading →

In response to recent conjecture, the White House has confirmed that U.S. President Joe Biden is not undergoing treatment for Parkinsons disease. What Happened: The statement was made following a New York Times disclosure that a Parkinsons specialist had been to the White House eight times from August to March Continue reading →

Mission Therapeutics has received $5.2 million from The Michael J. Fox Foundation (MJFF) and Parkinsons UK to start clinical testing MTX325, its experimental and neuron-protective oral therapy, in people in the early stages of Parkinsons disease. This significant grant, from two of the worlds leading Parkinsons disease organisations, underlines the huge potential of MTX325 as a disease-modifying treatment for this terrible neurodegenerative illness, Anker Lundemose, Missions CEO, said in a company press release. Continue reading →

1/1 Swipe or click to see more REUTERS/ELIZABETH FRANTZ/FILE PHOTO President Joe Biden walks to deliver remarks after the U.S. Supreme Court ruled on former U.S. President and Republican presidential candidate Donald Trumps bid for immunity from federal prosecution for 2020 election subversion, at the White House in Washington, on July 1. Continue reading →

A doctor who is an expert on Parkinsons disease reportedly visited the White House on a fairly regular basis in the past year, including at least once for a meeting with President Bidens personal physician. Dr. Kevin Cannard, a neurologist who recently published a paper on Parkinsons, made eight White House visits in an eight-month period from last summer through this past March, according to visitor logs obtained by The New York Times Continue reading →

The White House admitted Monday that a Parkinsons expert whos visited the executive mansion eight times in as many months has evaluated President Biden but said the exams only took place during the presidents annual physicals. The revelation was disclosed in a letter from Bidens personal physician Dr. Continue reading →

The U.S. Continue reading →

-synuclein regulates neurotransmitter release, supports learning and memory, and maintains neuronal health (1). Continue reading →